NEW YORK (GenomeWeb) – Pathway Genomics today announced that it has raised $40 million in a Series E round of financing.

"This capital will allow us to continue to expand and validate the tests we offer, grow our sales force, and invest in cutting-edge technology for our CAP- and CLIA-accredited laboratories," Pathway Genomics Founder and CEO Jim Plante said in a statement.

Among the participants in the round is IBM Watson, which is working with Pathway Genomics on the development of a mobile application for personalized health and wellness guidance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.